BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma

Cancer Research

Volumn 63, Issue 14, 2003, Pages 3883-3885

  Dong, Jianli ^a   Phelps, Robert G ^a   Qiao, Rui ^a   Yao, Shen ^a   Benard, Outhiriaradjou ^a   Ronai, Zeev ^a   Aaronson, Stuart A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAF GENE; CANCER GROWTH; DNA DETERMINATION; GENE MUTATION; HUMAN; HUMAN CELL; MELANOMA; METASTASIS; NUCLEOTIDE SEQUENCE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

DISEASE PROGRESSION; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MUTATION; NEVUS, PIGMENTED; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0042743826     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W., Leung, S. Y., Yuen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R., and Futreal, P. A. Mutations of the BRAF gene in human cancer. Nature (Lond.), 417: 949-954, 2002.
2. Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., Salem, G., Pohida, T., Heenan, P., Duray, P., Kallioniemi, O., Hayward, N. K., Trent, J. M., and Meltzer, P. S. High frequency of BRAF mutations in nevi. Nat. Genet., 33: 19-20, 2002.
3. Brose, M. S., Volpe, P., Feldman, M., Kumar, M., Rishi, I., Gerrero, R., Einhorn, E., Herlyn, M., Minna, J., Nicholson, A., Roth, J. A., Albelda, S. M., Davies, H., Cox, C., Brignell, G., Stephens, P., Futreal, P. A., Wooster, R., Stratton, M. R., and Weber, B. L. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res., 62: 6997-7000, 2002.
4. Guerry, D., IV, Synnestvedt, M., Elder, D. E., and Schultz, D. Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. J. Investig. Dermatol., 100: 342S-345S, 1993.
5. Crowson, A. N., Magro, C. M., and Mihm, M. C. The melanocytic proliferations. A comprehensive textbook of pigmented lesions, pp. 281-398, New York: Wiley-Liss, 2001.
6. Jiveskog, S., Ragnarsson-Olding, B., Platz, A., and Ringborg, U. N-Ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J. Investig. Dermatol., 111: 757-761, 1998.
7. Clark, W. H., Jr., and Tucker, M. A. Problems with lesions related to the development of malignant melanoma: common nevi, dysplastic nevi, malignant melanoma in situ, and radial growth phase malignant melanoma. Hum. Pathol., 29: 8-14, 1998.
8. Elder, D. Tumor progression, early diagnosis and prognosis of melanoma. Acta Oncol., 38: 535-547, 1999.
9. Kanzler, M. H., and Mraz-Gemhard, S. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview. J. Am. Acad. Dermatol., 45: 260-276, 2001.
10. Zhu, J., Woods, D., McMahon, M., and Bishop, J. M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev., 12: 2997-3007, 1998.
11. Lin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., and Lowe, S. W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev., 12: 3008-3019, 1998.
12. Sewing, A., Wiseman, B., Lloyd, A. C., and Land, H. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol. Cell. Biol., 17: 5588-5597, 1997.
13. Woods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., and McMahon, M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol., 17: 5598-5611, 1997.
14. Groth, A., Weber, J. D., Willumsen, B. M., Sherr, C. J., and Roussel, M. F. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases. J. Biol. Chem., 275: 27473-27480, 2000.
15. Zhang, Y., and Xiong, Y. Control of p53 ubiquitination and nuclear export by MDM2 and ARF. Cell Growth Differ., 12: 175-186, 2001.
16. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
17. Vogelstein, B., Lane, D., and Levine, A. J. Surfing the p53 network, Nature (Lond.), 408: 307-310, 2000.
18. Boulaire, J., Fotedar, A., and Fotedar, R. The functions of the cdk-cyclin kinase inhibitor p21WAF1. Pathol. Biol., 48: 190-202, 2000.